Positron emission tomography image on evaluating intraperitoneal dissemination of malignant gastrointestinal stromal tumor

Hepato-Gastroenterology

Volumn 55, Issue 84, 2008, Pages 895-897

  Kobayashi, Yoshinao ^a   Nakao, Makoto ^a   Konishi, Masayshi ^a   Urawa, Naohito ^a   Iwasa, Motoh ^a   Kaito, Masahiko ^a   Adachi, Yukihiko ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Gastrointestinal stromal tumor; Greater omentum; Positron emission tomography

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CALCIUM; CD34 ANTIGEN; ELCATONIN; FLUORODEOXYGLUCOSE F 18; GAMMA GLUTAMYLTRANSFERASE; IMATINIB; INTERLEUKIN 2 RECEPTOR; PAMIDRONIC ACID; STEM CELL FACTOR RECEPTOR;

ADULT; ANAMNESIS; ARTICLE; AUTOPSY; BACTERIAL PERITONITIS; CASE REPORT; CAUSE OF DEATH; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; GASTROINTESTINAL STROMAL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; IMMUNOHISTOCHEMISTRY; INTESTINE NECROSIS; KIDNEY FAILURE; LABORATORY TEST; MALE; NEEDLE BIOPSY; PERITONEUM METASTASIS; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SEPTIC SHOCK;

AGED; BIOPSY, NEEDLE; BLOOD GLUCOSE; DIAGNOSIS, DIFFERENTIAL; FLUORODEOXYGLUCOSE F18; GASTROINTESTINAL STROMAL TUMORS; HUMANS; INTESTINES; MALE; NECROSIS; OMENTUM; PERITONEAL NEOPLASMS; PERITONITIS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 47149098193     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Gelibter A, Milella M, Ceribelli A, Zeuli M, Ferraresi V, Vecchione A, Cognetti F: PET scanning evaluation of response to imatinib mesylate therapy in gastrointestinal stromal tumor (GIST) patients. Anticancer Res 2004; 24:3147-3151.
2. Suzuki K, Kaneko G, Kubota K, Horigome N, Hikita H, Senga O, Miyakawa M, Shimojo H, Uehara T, Itoh N: Malignant tumor, of the gastrointestinal stromal tumor type, in the greater omentum. J Gastroenterol 2003; 38:985-988.
3. Miettinen M, Monihan JM, Sarlomo-Rikala M, Kovatich AJ, Carr NJ, Emory TS, Sobin LH: Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery. Clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Pathol 1999; 23:1109-1118.
4. Graadt van Roggen JF, van Velthuysen ML, Hogen doom PC: The histopathological differential diagnosis of gastrointestinal stromal tumours. J Clin Pathol 2001; 54:96-102.
5. Goerres GW, Stupp R, Barghouth G, Hany TF, Pestalozzi B, Dizendorf E, Schnyder P, Luthi F, von Schulthess GK, Leyvraz S: The value of PET, CT and inline PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate. Eur J Nucl Med Mol Imaging 2005; 32:153-162.
6. Gelibter A, Milella M, Ceribelli A, Zeuli M, Ferraresi V, Vecchione A, Cognetti F: PET scanning evaluation of response to imatinib mesylate therapy in gastrointestinal stromal tumor (GIST) patients. Anticancer Res 2004; 24:3147-3151.
7. Sugar I, Forgacs B, Istvan G, Bognar G, Sapy Z, Ondrejka P: Gastrointestinal stromal tumors (GIST). Hepatogastroenterology 2005; 52:409-413.